Federated Hermes’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-154,192
Closed -$4.4M 2132
2024
Q3
$4.4M Buy
+154,192
New +$4.55M 0.01% 748
2024
Q1
Sell
-2,979
Closed -$126K 2081
2023
Q4
$126K Sell
2,979
-356,609
-99% -$13.1M ﹤0.01% 1569
2023
Q3
$13.8M Buy
359,588
+310,163
+628% +$7.01M 0.04% 459
2023
Q2
$938K Sell
49,425
-3,067
-6% -$57.2K ﹤0.01% 1157
2023
Q1
$814K Buy
52,492
+9,924
+23% +$172K ﹤0.01% 1234
2022
Q4
$756K Buy
42,568
+32,708
+332% +$412K ﹤0.01% 1226
2022
Q3
$55K Sell
9,860
-1,872,491
-99% -$9.15M ﹤0.01% 1661
2022
Q2
$7.34M Sell
1,882,351
-21,543
-1% -$93.1K 0.02% 614
2022
Q1
$10.5M Buy
1,903,894
+1,404,404
+281% +$8.75M 0.02% 592
2021
Q4
$4.26M Buy
499,490
+486,456
+3,732% +$4.02M 0.01% 859
2021
Q3
$113K Buy
+13,034
New +$118K ﹤0.01% 1756
2021
Q1
Sell
-171,059
Closed -$7.9M 2283
2020
Q4
$7.9M Buy
171,059
+149,193
+682% +$6.9M 0.02% 699
2020
Q3
$769K Buy
+21,866
New +$658K ﹤0.01% 1350

Other funds holding IMVT